Acid-degradable hollow calcium-manganese nanocarriers integrate calcium stress, redox catalysis, and antitumor immunity for lung cancer therapy
Acta Biomaterialia · 2026-11 · 225 · 805-826
DOI: 10.1016/j.actbio.2026.10.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-11. Verfasst von Wei Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Calcium, Manganese, Nanoparticles. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Harbin Medical University, Beijing Medical Award Foundation, Harbin Institute of Technology.
Abstract (Originalsprache)
Non-small cell lung cancer (NSCLC) remains a major cause of cancer-related mortality, while acquired resistance to EGFR-targeted therapy and an immunosuppressive tumor microenvironment continue to limit therapeutic efficacy. Here, we developed a tumor cell membrane-coated, acid-degradable hollow calcium-manganese nanoplatform loaded with gefitinib (CM@HCC-Mn/Gef) for combined redox modulation and antitumor immune activation. Under acidic and redox-active conditions, CM@HCC-Mn/Gef released gefitinib, Ca2+, and Mn2+, leading to intracellular Ca2+ accumulation, mitochondrial depolarization, ATP depletion, reactive oxygen species generation, glutathione consumption, GPX4 downregulation, and lipid peroxidation. These coordinated effects induced ferroptosis-associated oxidative damage and immunogenic cell death (ICD), characterized by cell-surface calreticulin exposure and HMGB1 redistribution, and subsequently promoted dendritic cell maturation and T-cell activation. In gefitinib-resistant NSCLC cells, CM@HCC-Mn/Gef produced substantially greater cytotoxicity than free gefitinib, indicating that multimechanistic stress amplification enhanced the therapeutic response of resistant tumor cells. In immunocompetent syngeneic LLC tumor models, the nanoplatform inhibited primary tumor growth, increased tumor-infiltrating T cells, alleviated immunosuppressive features of the tumor microenvironment, and delayed contralateral secondary tumor progression. Combination with anti-PD-1 further enhanced tumor suppression and systemic immune activation. Collectively, CM@HCC-Mn/Gef integrates targeted drug delivery, calcium-associated mitochondrial stress, redox disruption, ferroptosis-associated damage, and immune activation, providing a biomimetic nanotherapeutic strategy for NSCLC chemoimmunotherapy. STATEMENT OF SIGNIFICANCE: Conventional nanocarriers often provide drug delivery without coordinating multiple tumor-specific stresses and immune activation. This study introduces a tumor cell membrane-coated, acid-degradable hollow calcium-manganese nanoplatform that co-releases gefitinib, Ca2+, and Mn2+ in the tumor microenvironment. The material couples calcium-associated mitochondrial dysfunction with manganese-driven redox catalysis, thereby enhancing oxidative damage, lipid peroxidation, and immunogenic cell death-associated responses. It also improves tumor accumulation, promotes dendritic cell maturation and T-cell activation, and enhances anti-PD-1 therapy in immunocompetent lung cancer models. This work establishes a direct link between biomaterial composition, stimulus-responsive degradation, catalytic function, and antitumor immunity, offering a versatile design strategy for biomaterials-enabled chemoimmunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.
- Department of Medical oncology, Harbin Medical University Cancer Hospital, Harbin, China.
- Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
- Department of Thoracic Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China.
- Department of Medical oncology, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: Zhaoyanbin1978@sina.com.
- Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: ningjf@hrbmu.edu.cn.
Förderung
- Harbin Medical University
- Beijing Medical Award Foundation
- Harbin Institute of Technology
- National Natural Science Foundation of China
Zitieren
APA
Liu, W., Yang, M., Wang, F., Yin, H., Zhai, S., Zhou, F., Gao, Q., He, J., Zhao, Y., & Ning, J. (2026). Acid-degradable hollow calcium-manganese nanocarriers integrate calcium stress, redox catalysis, and antitumor immunity for lung cancer therapy. Acta Biomaterialia, 225, 805-826. https://doi.org/10.1016/j.actbio.2026.10.015
Vancouver
Liu W, Yang M, Wang F, Yin H, Zhai S, Zhou F, et al. Acid-degradable hollow calcium-manganese nanocarriers integrate calcium stress, redox catalysis, and antitumor immunity for lung cancer therapy. Acta Biomaterialia. 2026;225:805-826. doi:10.1016/j.actbio.2026.10.015
BibTeX
@article{Liu2026,
author = {Liu, Wei and Yang, Maopeng and Wang, Fengjiao and Yin, Hongtao and Zhai, Shuyi and Zhou, Fucheng and Gao, Qiang and He, Jinrui and Zhao, Yanbin and Ning, Jinfeng},
title = {Acid-degradable hollow calcium-manganese nanocarriers integrate calcium stress, redox catalysis, and antitumor immunity for lung cancer therapy},
journal = {Acta Biomaterialia},
year = {2026},
volume = {225},
pages = {805--826},
doi = {10.1016/j.actbio.2026.10.015}
}
EUVIMED